Digital tools for diabetes management

Topic Status Complete

Digital platforms for personalised diabetes management, education and support in adults

Outcome of the appraisal

 

The evidence supports the routine adoption of the MyWay Diabetes digital platform for personalised management, education, and support for people with type 2 diabetes.
In people with type 2 diabetes who do not require insulin, the MyWay Diabetes digital platform is associated with improved glycaemic control compared to standard care.
Economic modelling suggests MyWay Diabetes is cost effective compared with standard care in people with type 2 diabetes who do not require insulin with an incremental cost-effectiveness ratio (ICER) of £4,577 per quality-adjusted life-year (QALY).
The evidence does not support the use of other digital platforms for people with type 2 diabetes and HTW recommends further research on the use of other digital platforms for personalised management, education, and support in these patients.
The evidence does not support the routine adoption of digital platforms for personalised management, education, and support for people with type 1 diabetes. HTW recommends further research on the use of such platforms for people with type 1 diabetes.

Why was this topic appraised?

 

The prevalence of diabetes in the UK is expected to rise and currently accounts for approximately 10% of the NHS annual budget. It is estimated that 80% of this amount is spent on treating the complications of diabetes. In Wales, the prevalence of diabetes is the highest of any other country in the UK. Educating those with diabetes on how to best manage their condition is one of the ways in which diabetes treatment can be improved and associated complications minimised. Digital tools and platforms such as mobile applications can aid self-management and education and thus could lead to improvements in the lifestyle factors that are associated with risk and the development of diabetes related complications. Digital platforms included in this review include those that provide personalised advice and education which can be driven using artificial intelligence, machine learning or through the application of data rules. This topic was submitted by the CEO/Co-Founder of MyWay Digital Health, which owns a portfolio of digital platforms including MyWay Diabetes, previously known as My Diabetes My Way (MDMW).

Plain language summary

 

 

Diabetes is a condition that causes a person’s blood sugar level, or glucose level, to become too high. Glucose is the bodies main source of energy, and it can be produced by the body as well as taken from food that has been eaten. Levels of glucose in the blood are usually managed by a hormone called insulin. Insulin helps glucose get into cells to be used for energy. For people who don’t produce insulin (type 1 diabetes) or who’s body doesn’t use insulin properly (type 2 diabetes), glucose remains in the blood and doesn’t reach cells. This can lead to damage of the heart, kidneys, feet and eyes. It is therefore important to monitor the levels of glucose in the blood and take appropriate action if there is too much or too little.

Managing diabetes can be a huge task that can include taking glucose readings several times a day, taking insulin through injections or pump systems, taking medication and making everyday decisions to help lower or raise glucose levels. Eating certain foods and undertaking exercise can have a big impact on glucose levels. Knowing what diabetes is, how it can be managed, and being supported to make decisions can help people with diabetes better manage their condition.

Digital tools for the management and education may help adults with diabetes to manage their condition at home. They can be used to help enable good decision making as well as better communication with healthcare professionals.

Health Technology Wales looked for evidence on the use of digital tools for diabetes management and education. The evidence supports the routine adoption of the MyWay Diabetes digital platform for personalised management, education, and support for people with type 2 diabetes.

Topic Exploration Report

TER450 05.2023

Evidence Appraisal Review

EAR054 12.2024

Guidance

GUI054 12.2024

GUI